MustGrow Biologics (OTC:MGROF) Shares Up 4.7% – Still a Buy?

MustGrow Biologics Corp. (OTC:MGROFGet Free Report) was up 4.7% during trading on Tuesday . The company traded as high as C$0.65 and last traded at C$0.64. Approximately 3,350 shares were traded during mid-day trading, a decline of 52% from the average daily volume of 6,961 shares. The stock had previously closed at C$0.61.

MustGrow Biologics Trading Up 4.7%

The stock has a fifty day moving average price of C$0.45 and a two-hundred day moving average price of C$0.49.

About MustGrow Biologics

(Get Free Report)

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets.

Further Reading

Receive News & Ratings for MustGrow Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MustGrow Biologics and related companies with MarketBeat.com's FREE daily email newsletter.